Evidence map›Paper›PMID 35449918›Full record

ArticleACS omega2022

Hafnium-Based Metal-Organic Framework Nanoparticles as a Radiosensitizer to Improve Radiotherapy Efficacy in Esophageal Cancer.

Wei Zhou, Zhulong Liu, Nana Wang, Xue Chen, Xiaozheng Sun, Yufeng Cheng

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 70 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Targeting the organelle for radiosensitization in cancer radiotherapy.Asian journal of pharmaceutical sciences · 2024
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Wei ZhouDepartment of Radiation Oncology, Cheeloo College of Medicine, Qilu Hospital, Shandong University, Jinan 250100, China.
Zhulong LiuDepartment of Radiation Oncology, Cheeloo College of Medicine, Qilu Hospital, Shandong University, Jinan 250100, China.
Nana WangDepartment of Radiation Oncology, Cheeloo College of Medicine, Qilu Hospital, Shandong University, Jinan 250100, China.
Xue ChenDepartment of Radiation Oncology, Cheeloo College of Medicine, Qilu Hospital, Shandong University, Jinan 250100, China.
Xiaozheng SunDepartment of Radiation Oncology, Cheeloo College of Medicine, Qilu Hospital, Shandong University, Jinan 250100, China.
Yufeng ChengDepartment of Radiation Oncology, Cheeloo College of Medicine, Qilu Hospital, Shandong University, Jinan 250100, China.ORCID https://orcid.org/0000-0003-1466-3115
Qilu Hospital of Shandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiotherapy is one of the most widely used clinical treatments for tumors, but it faces limitations, such as poor X-ray retention at the tumor site. The use of radiosensitizers containing high

Identifiers

PMID35449918
PMCPMC9016869
OpenAlexW4221034214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.